HPGC Renmintongtai Pharmaceutical Corporation (SHA:600829)
China flag China · Delayed Price · Currency is CNY
9.68
+0.04 (0.41%)
Apr 29, 2026, 3:00 PM CST

SHA:600829 Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Apr '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
5,6136,2694,3494,5353,7003,897
Market Cap Growth
24.10%44.13%-4.09%22.57%-5.06%-9.43%
Enterprise Value
5,4856,3824,4994,6543,9124,575
Last Close Price
9.6810.817.507.626.226.55
PE Ratio
41.1446.8420.3915.5213.9914.05
PS Ratio
0.530.600.430.440.380.42
PB Ratio
1.832.081.511.651.511.77
P/TBV Ratio
1.852.101.521.661.521.80
P/FCF Ratio
22.8322.1740.5014.6512.30-
P/OCF Ratio
21.2920.9037.6813.6212.04-
EV/Sales Ratio
0.520.620.450.450.410.49
EV/EBITDA Ratio
19.0726.3114.0510.789.6910.48
EV/EBIT Ratio
23.7328.2715.0011.3110.2111.08
EV/FCF Ratio
22.3122.5741.8915.0413.00-
Debt / Equity Ratio
0.250.240.310.370.520.60
Debt / EBITDA Ratio
2.632.592.492.162.842.80
Debt / FCF Ratio
3.072.598.383.294.22-
Net Debt / Equity Ratio
-0.04-0.17-0.07-0.110.040.24
Net Debt / EBITDA Ratio
-0.52-2.07-0.62-0.680.221.21
Net Debt / FCF Ratio
-0.52-1.78-1.86-0.950.29-2.15
Asset Turnover
1.451.451.381.441.401.46
Inventory Turnover
8.308.188.298.598.027.48
Quick Ratio
1.321.341.331.271.221.15
Current Ratio
1.661.671.621.531.481.42
Return on Equity (ROE)
4.56%4.54%7.57%11.22%11.36%13.19%
Return on Assets (ROA)
1.98%1.97%2.57%3.55%3.47%4.05%
Return on Invested Capital (ROIC)
5.99%6.14%8.61%12.23%11.12%12.97%
Return on Capital Employed (ROCE)
7.20%7.10%9.90%14.20%14.60%17.30%
Earnings Yield
2.43%2.14%4.90%6.44%7.15%7.12%
FCF Yield
4.38%4.51%2.47%6.83%8.13%-6.29%
Dividend Yield
---1.89%--
Payout Ratio
9.96%15.00%75.22%8.43%11.53%12.86%
Buyback Yield / Dilution
-0.03%-0.01%0.01%-0.01%0.00%0.20%
Total Shareholder Return
-0.03%-0.01%0.01%1.88%0.00%0.20%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.